Exploring infant feeding practices: cross-sectional surveys of South Western Sydney, Singapore, and Ho Chi Minh City

Leow, Timothy; Ung, Andrew; Qian, Shelley; Nguyen, Jessie Thanh; An, Yvonne; Mudgil, Poonam; Whitehall, John

doi:10.1186/s12887-017-0902-0

Cited by 9 publications

(7 citation statements)

References 39 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Although high rates of breastfeeding are reported in this study, bottlefeeding and supplemental feeding practices are not recorded. Other studies show high rates of mixed feeding [51] and bottle-feeding [52] in Vietnamespecially supplemental feeding with sweetened liquids and foods [53] that is associated with increased risk of child obesity [54]. Children of mothers with higher education may have greater risk of ow/ob because educated mothers may be working outside the home, curtailing the duration of breastfeeding, and leaving the child's caregiver with money to buy "treats" such as snacks or sugary drinks [55,56].…”

Section: Discussionmentioning

confidence: 99%

Early childhood factors associated with obesity at age 8 in Vietnamese children: The Young Lives Cohort Study

et al. 2021

View full text Add to dashboard Cite

Background Over recent decades, Vietnam has experienced rapid economic growth, a nutrition transition from the traditional diet to highly-processed and calorie-dense foods and beverages, and an increasing prevalence of childhood overweight/obesity (ow/ob). The goal of this study is to describe the patterns of ow/ob in a longitudinal sample of Vietnamese children from ages 1 to 8, and the sociodemographic and behavioral factors associated with ow/ob at age 8. Methods This study is a secondary data analysis of a geographically-representative, longitudinal cohort of 1961 Vietnamese children from the Young Lives Cohort Study from 2002 to 2009. Thirty-one communities were selected with oversampling in rural communities, and children age 1 were recruited from each community using simple random sampling. Surveys of families and measurements of children were collected at child ages 1, 5, and 8. Our specified outcome measure was childhood ow/ob at age 8, defined by the World Health Organization’s thresholds for body-mass-index (BMI) for age Z-scores. Associations between early and concurrent socio-behavioral factors, childhood nutrition and physical activity variables were analyzed using STATA 15. Bivariate and multivariable analyses were completed utilizing logistic regression models. Results The prevalence of ow/ob increased from 1.1% in both sexes at age 1 to 7% in females and 13% in males at age 8. Bivariate analyses show greater likelihood of ow/ob at age 8 was significantly associated with early life sociodemographic factors (at age 1), male sex (OR = 2.2, 1.6–3.1), higher wealth (OR = 1.1–1.4), and urban residence (OR = 4.3, 3–6). In adjusted analyses, ow/ob at age 8 was associated with early nutrition practices at age 5, including frequent consumption of powdered milk (OR = 2.8, 1.6–4.6), honey/sugar (OR = 2.7, 1.8–4.1), prepared restaurant/fast foods (OR = 4.6, 2.6–8.2), and packaged sweets (OR = 3.4, 2.3–4.9). In addition, breastfeeding for 6 months or longer was protective against obesity at age 8 (OR = 0.3, 0.1–0.9). Conclusions We found that increased consumption of powdered milk, honey/sugar, packaged sweets, and prepared restaurants/fast foods are associated with childhood ow/ob. In contrast, breastfeeding for 6 months or longer was protective against childhood ow/ob. These findings suggest that public health programs and campaigns aimed to prevent childhood ow/ob in Vietnam should target early feeding practices.

show abstract

Section: Discussionmentioning

confidence: 99%

Early childhood factors associated with obesity at age 8 in Vietnamese children: The Young Lives Cohort Study

et al. 2021

View full text Add to dashboard Cite

show abstract

“…We did not periodically assess maternal perception of breastmilk su ciency; metoclopramide-users may have developed low self-e ciency leading to early cessation despite successful initiation (32). Social support may only have limited success in mitigating these effects (33), and are less likely to succeed in communities with low breastfeeding prevalence like Singapore (34,35). Increasing awareness of the bene ts of breastfeeding for mother and infant, especially of the reduced long-term risk of metabolic conditions in breast-fed infants creates a stronger incentive to improve lactation through a multidisciplinary approach (35,36).…”

Section: Discussionmentioning

confidence: 99%

Early postpartum oral metoclopramide augments lactogenesis II in insulin-dependent mothers with gestational diabetes: a randomized placebo-controlled trial

Fok¹,

Chan²,

Ho³

et al. 2020

Preprint

View full text Add to dashboard Cite

Background Mothers with gestational diabetes are at risk of lactogenesis II delayed beyond the third postnatal day and early breastfeeding cessation, which may be overcome by prophylactic intervention. Research aim To evaluate the effect of oral metoclopramide commenced within twelve hours of delivery on lactogenesis II in mothers with insulin-dependent (iGDM) or diet-controlled (dGDM) gestational diabetes. Methods Between July 2006 and January 2009, 73 mothers of term neonates (iGDM, n=20 and dGDM, n=53) were randomized to the metoclopramide (n=37) or placebo groups (n=36). Mothers with gestational diabetes in the intervention group received 30mg of oral metoclopramide daily for the first postnatal week in a randomized double-blinded placebo-controlled study. Primary outcome was lactogenesis II onset by postnatal day 3, while secondary outcomes included expressed human milk volumes (EHM) and exclusive breastfeeding rates and infant weight change.Results 40% more iGDM metoclopramide users achieved lactogenesis II by postnatal day 3 (p=0.01), with 4.8-fold EHM increase over controls (p=0.04); 50% of iGDM mothers perceived lactogenesis II onset by day 2 and more rapid EHM accumulation was observed in all metoclopramide users. Despite this, metoclopramide-users demonstrated less exclusive breastfeeding, earlier cessation and more frequent formula-feeding. Conclusions Short-term metoclopramide uses within the first 12 postnatal hours significantly improved daily EHM production and maternal perception of lactogenesis II onset in iGDM mothers. Treated iGDM mothers did not experience the natural EHM decrease of iGDM placebo-users. The low breastfeeding rate suggested that physiological breastfeeding barriers may not modifiable by metoclopramide or traditional lactation support.

show abstract

“…We did not periodically assess maternal perception of breastmilk su ciency; metoclopramide-users may have developed low self-e ciency leading to early cessation despite successful initiation (32). The common rst-line interventions of optimizing breastfeeding technique and feeding frequency may not effectively address low milk supply in this context, while social support may only have limited success in mitigating these effects (33), and are less likely to succeed in communities with low breastfeeding prevalence like Singapore (34)(35)(36). These ndings reiterate the need for wholistic support in identi ed atrisk mothers who will bene t from speci c interventions initiated within an hour of birth, as recommended by the American College of Obstetrics and Gynaecology (37).…”

Section: Discussionmentioning

confidence: 99%

Oral metoclopramide boosts lactogenesis II in mothers with preterm infants: a randomized placebo-controlled trial.

Fok¹,

Chan²,

Ho³

et al. 2020

Preprint

View full text Add to dashboard Cite

Background: Preterm mothers at risk of delayed lactogenesis II may benefit from early pharmcological intervention to initiate breastfeeding onset. Research aim. To evaluate the effect of oral metoclopramide on lactogenesis II in mothers of preterm infants commencing within twelve hours of delivery. Methods: From April 2006 to May 2009,105 women were randomized to metoclopramide (term births, n=36;reterm n=20) or placebo (term,n=33;preterm,n=16). Mothers received 30 mg of oral metoclopramide daily for the first postnatal week in a randomized double-blinded placebo-controlled study. Primary outcome was augmentation of Lactogenesis II onset by postnatal day 3. Secondary outcomes were daily expression of breastmilk and maternal perception of lactogenesis II, breastfeeding practice and infant weight change over 6 months. Results: Metoclopramide achieved 25% augmentation in lactogenesis II onset (p=0.09) with greater expressed human milk volumes in mothers of preterm infants. Daily expressed human milk volumes was higher among preterm mothers on metoclopramide compared to term placebo mothers who served as controls, significant on day 2 (19.9 vs 2.4ml, p=0.04) and day 3 (32.6 vs 8.8ml,p=0.04),and total expressed human milk volumes had increased by 8.2 fold by the end of week one. Most mothers reported first initiation of lactogenesis II by day 6, with 95-100% of term mothers confirmed by day 5 (not significant). Conclusions: Short-term metoclopramide use starting within 12 postnatal hours boosted lactogenesisi II onset in preterm mothers, improving daily expressed human milk production and maternal perception of lactogenesis II onset.

show abstract

Exploring infant feeding practices: cross-sectional surveys of South Western Sydney, Singapore, and Ho Chi Minh City

Cited by 9 publications

References 39 publications

Early childhood factors associated with obesity at age 8 in Vietnamese children: The Young Lives Cohort Study

Early childhood factors associated with obesity at age 8 in Vietnamese children: The Young Lives Cohort Study

Early postpartum oral metoclopramide augments lactogenesis II in insulin-dependent mothers with gestational diabetes: a randomized placebo-controlled trial

Oral metoclopramide boosts lactogenesis II in mothers with preterm infants: a randomized placebo-controlled trial.

Contact Info

Product

Resources

About